IPCA Laboratories share price
You have to be logged in to add this to Watchlist.IPCA Laboratories is trading 0.97% upper at Rs 1,606.00 as compared to its last closing price. IPCA Laboratories has been trading in the price range of 1,622.40 & 1,596.05. IPCA Laboratories has given 42.96% in this year & 5.75% in the last 5 days.
IPCA Laboratories has TTM P/E ratio 57.47 as compared to the sector P/E of 33.29.There are 12 analysts who have initiated coverage on IPCA Laboratories. There are 3 analysts who have given it a strong buy rating & 5 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.
The company posted a net profit of 229.48 Crores in its last quarter.
Listed peers of IPCA Laboratories include Glenmark Pharmaceuticals (0.91%), Glaxosmithkline Pharmaceuticals (-2.87%), IPCA Laboratories (0.97%) etc.
IPCA Laboratories has a 53.70% public holding.The Mutual Fund holding in IPCA Laboratories was at 28.55% in 30 Sep 2024. The MF holding has increased from the last quarter. The FII holding in IPCA Laboratories was at 10.83% in 30 Sep 2024. The FII holding has decreased from the last quarter.
IPCA Laboratories share price range
|
| ||||
|
| ||||
IPCA Laboratories share Key Metrics
| Market Cap ( ₹ Cr.) | 40,373.22 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
IPCA Laboratories Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 14-Nov-24 | Quarterly Results & Interim Dividend |
| 30-Sep-24 | Others |
| 13-Aug-24 | Quarterly Results |
| 29-May-24 | Audited Results & Final Dividend |
| 14-Feb-24 | Quarterly Results |
| 10-Nov-23 | Quarterly Results & Interim Dividend |
| 10-Aug-23 | Quarterly Results |
| 29-May-23 | Audited Results |
| 14-Feb-23 | Quarterly Results |
| 11-Nov-22 | Quarterly Results & Interim Dividend |
| Meeting Date | Announcement On | Purpose |
| 13-Aug-24 | 18-Jul-24 | AGM |
| 30-Mar-24 | 23-Feb-24 | POM |
| 10-Aug-23 | 29-May-23 | AGM |
| 31-Mar-23 | 24-Feb-23 | POM |
| 02-Sep-21 | 04-Aug-21 | AGM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 24-Oct-24 | 25-Nov-24 | 25-Nov-24 | 2 |
| 29-May-24 | - | 06-Aug-24 | 2 |
| 26-Oct-23 | 22-Nov-23 | 22-Nov-23 | 2 |
| 02-Nov-22 | 23-Nov-22 | 22-Nov-22 | 4 |
| 20-Oct-21 | 23-Nov-21 | 22-Nov-21 | 8 |
| Ex-Splits | Old FV | New FV | Description |
| 10-Jan-22 | 2 | 1 | Stock split from Rs. 2/- to Re. 1/-. |
FAQs about IPCA Laboratories share price
IPCA Laboratories is trading at 1606.00 as on Mon Nov 25 2024 09:59:24. This is 0.97% upper as compared to its previous closing price of 1590.55.
The market capitalization of IPCA Laboratories is 40373.22 Cr as on Mon Nov 25 2024 09:59:24.
The average broker rating on IPCA Laboratories is Buy. The breakup of analyst rating is given below -
- 3 analysts have given a strong buy rating
- 5 analysts have given a buy rating
- 2 analysts have given a hold rating
- 2 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for IPCA Laboratories is 1708.70 whereas the 52 wk low is 1042.00
IPCA Laboratories can be analyzed on the following key metrics -
- TTM P/E: 57.47
- Sector P/E: 33.29
- Dividend Yield: 0.25%
- D/E ratio: 0.18
IPCA Laboratories reported a net profit of 547.35 Cr in 2024.
IPCA Laboratories Quick Links
IPCA Laboratories Dividend IPCA Laboratories Bonus IPCA Laboratories News IPCA Laboratories AGM IPCA Laboratories Rights IPCA Laboratories Splits IPCA Laboratories Board Meetings IPCA Laboratories Key Metrics IPCA Laboratories Shareholdings IPCA Laboratories Profit Loss IPCA Laboratories Balance Sheet IPCA Laboratories Cashflow IPCA Laboratories Q1 Results IPCA Laboratories Q2 Results IPCA Laboratories Q3 Results IPCA Laboratories Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks